Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Uptake of the Angiogenesis PET Tracer 68Ga-NODAGA-E[c(RGDyK)]2 Correlates Strongly with Angiopoietin-1 and Angiopoietin-2 Expression in Human Neuroendocrine Xenograft Tumors in Mice

Jytte Oxboel, Malene Brandt-Larsen, Jacob Madsen and Andreas Kjaer
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1367;
Jytte Oxboel
1Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Copenhagen Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malene Brandt-Larsen
1Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Copenhagen Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Madsen
1Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Copenhagen Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Kjaer
1Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen Copenhagen Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1367

Objectives Validation of the angiogenesis PET tracer 68Ga-NODAGA- E[c(RGDyK)]2 targeting integrin αVβ3: comparison of tracer uptake (% ID/g) with gene expression of integrin β3 (ITGB3), angiopoietin-1 (ANG-1) and angiopoietin-2 (ANG-2) in human neuroendocrine xenograft tumors (NCI-H727) in nude mice. 68Ga-NODAGA- E[c(RGDyK)]2 is a promising candidate for validating tumor-angiogenesis, because RGD peptide targets integrin αVβ3 which are markers of neo-angiogenesis. In addition, the Angiopoietin proteins (ANG-1 and ANG-2) have an important role in vascular development and angiogenesis. ANG-2 has been established as an antagonist inhibiting ANG-1 activation of its receptor Tyrosine Kinase (TIE-2). Binding of ANG-1 to TIE-2 has an important stabilizing effect on the vasculature, whereas binding of ANG-2 to the same receptor destabilizes vessels. ANG-2 promotes vascular sprouting and destabilizes blood vessels in presence of Vascular Endothelial Growth Factor (VEGF-A). In absence of VEGF-A ANG-2 contributes to vascular regression. ANG-2´s unique role in angiogenesis during development, growth and metastasis has been investigated in various human cancers and makes ANG-2 an attractive therapeutic target.

Methods 68Ga-NODAGA- E[c(RGDyK)]2 was synthesis using a 50 mCi 68Ge/68Ga generator and 2 nmol NODAGA- E[c(RGDyK)]2 actetate resulting in a radiochemical purity of 89-99%. Female NMRI nude mice were inoculated subcutaneously on both flanks with 1x107 human lung bronchus carcinoid cells (NCI-H727). Some weeks after inoculation, at a mean tumor volume of 332 mm3, mice were enrolled in the study (n= 10 tumors). PET scans were performed using a small animal PET scanner with a scan time of 15 minutes. Quantification of mean tracer uptake (% ID/g) in the xenograft tumors was performed using commercial image analysis software by drawing 3D regions of interest covering the whole tumor volume. Total RNAs were isolated from tumors using a column based separation kit obtaining 0.30- 0.45 µg/µl RNA. Real-time quantitative PCR was performed using a commercial kit and TaqMan chemistry for the QPCR quantification of genes of interest (GOI) and three optimized housekeeping genes. The relative gene expression levels were correlated to the tracer uptake values (% ID/g) as were the GOIs mutually.

Results Strong correlations were found between 68Ga-NODAGA- E[c(RGDyK)]2 uptake and h-ITGB3 (r=0.711; p=0.021), h-ANG-1 (r=0.851; p=0.002) and h-ANG-2 (r=0.838; p=0.003), respectively. Also strong correlations were found between genes pairwise: h-ITGB3 versus h-ANG-1 (r=0.665; p=0.036), versus h-ANG-2 (r=0.812; p=0.004), versus h-TIE-2 (r=0.945; p=<0.0001) furthermore h-ANG-1 versus h-ANG-2 (r=0.940; p=<0.0001).

Conclusions 68Ga-NODAGA-E[c(RGDyK)]2 is a promising candidate as companion diagnostic for Angiopoetin-directed therapies.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Uptake of the Angiogenesis PET Tracer 68Ga-NODAGA-E[c(RGDyK)]2 Correlates Strongly with Angiopoietin-1 and Angiopoietin-2 Expression in Human Neuroendocrine Xenograft Tumors in Mice
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Uptake of the Angiogenesis PET Tracer 68Ga-NODAGA-E[c(RGDyK)]2 Correlates Strongly with Angiopoietin-1 and Angiopoietin-2 Expression in Human Neuroendocrine Xenograft Tumors in Mice
Jytte Oxboel, Malene Brandt-Larsen, Jacob Madsen, Andreas Kjaer
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1367;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Uptake of the Angiogenesis PET Tracer 68Ga-NODAGA-E[c(RGDyK)]2 Correlates Strongly with Angiopoietin-1 and Angiopoietin-2 Expression in Human Neuroendocrine Xenograft Tumors in Mice
Jytte Oxboel, Malene Brandt-Larsen, Jacob Madsen, Andreas Kjaer
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1367;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Basic Science Posters

  • In Vivo PET/CT neuroimaging of radiolabeled nanocarriers following intranasal drug delivery (INDD): Validation using Ex Vivo PET/CT, gamma counting and autoradiography.
  • 18F-ML10 PET/CT demonstrates therapy-induced apoptosis in murine pancreatic adenocarcinoma
  • Generation of Orthotopic Xenograft Mouse Model of Prostate Cancer Validated by 11C-Choline PET/CT
Show more MTA I: Basic Science Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire